Dr Mo is Assistant Professor at Emory University School of Medicine in the Department of Pharmacology and Chemical Biology.
Dr. Mo's research is to understand the molecular basis underlying tumor initiation, progression and drug resistance, and to bridge the gap between vast cancer genomic dataset and unmet clinical need. His focus on SMAD4 is providing mechanistic insight in context-dependent manner to understand how SMAD4 loss-of-function mutation drives tumorigenesis but also now in SMAD4 gain of function in Myhre syndrome development.
8AM PST